retatrutide clinical trial safety How to Get in 2026 Retatrutide UK Guide: Key Facts

JAMA 332 , 952953 (2024)

CagriSema and Retatrutide are investigational compounds and are not FDA-approved for human treatment as described here

Something went wrong, but dont fret lets give it another shot

El frmaco tiene un efecto neutral sobre la glucemia, por lo que no se trata de un frmaco para la diabetes mellitus tipo 2, siendo su objetivo inicial la obesidad y la esteatosis heptica no alcohlica (donde se estn estudiando los beneficios de los ar-GLP1, entre otros)

Reductions in systolic and diastolic blood pressure, triglycerides, and markers of insulin resistance have also been observed, positioning retatrutide as a subject of broad interest across cardiometabolic research

Because of this triple action, retatrutide is being studied as a highly effective option for people struggling to lose weight